Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry

ConclusionsLower rates of unadjusted optimal medication use were seen in nonobCAD patients, driven by low clopidogrel use among medically managed patients, suggesting improvement efforts should focus on these patients.

Source: Clinical Cardiology - April 7, 2017 Category: Cardiology Authors: Reynaria Pitts, Stacie L. Daugherty, Fengming Tang, Philip Jones, P. Michael Ho, Thomas T. Tsai, John Spertus, Thomas M. Maddox Tags: QUALITY AND OUTCOMES Source Type: research